The results presented here indicates that PARP inhibition, through down-regulation of the intermediary filament vimentin in both endothelial and melanoma cells, led to a reversion of mesenchymal phenotype in both cell types and prevented malignant melanoma cells from developing vasculogenic mimicry. Here, VIM is linked to cancer.